New device eases migraines in kids as young as 6
NCT ID NCT06138756
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a wearable device called Nerivio for treating migraine in 293 children aged 6 to 11. The device uses mild electrical pulses to relieve headache pain without medication. Results showed it was safe and helped many children feel better within two hours.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Nerivio (remote electrical neuromodulation device)
- What this could lead to
- If this works, it could offer a drug-free option for easing migraine pain in young children.
- What could go wrong
- This was a small, single-arm study without a placebo group, so results may not be definitive. The device is already approved for older kids and adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Theranica Bio-Electronics Ltd
Netanya, 4250438, Israel
-
Theranica USA Inc
Bridgewater, New Jersey, 08807, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?